Spheroids Of Human Autologous Matrix-Associated Chondrocytes

CHEMBL5315113 Phase 4 Aprobado Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Spheroids of human autologous matrix-associated chondrocytes (Spherox) is an advanced therapy medicinal product consisting of cartilage-repair constructs made from the patient's own chondrocytes embedded in a collagen matrix, used for the surgical repair of full-thickness cartilage defects in the knee. The three-dimensional spheroid architecture maintains chondrocyte phenotype and supports integration with surrounding native cartilage after arthroscopic implantation. It represents a cell therapy approach to restore hyaline-like cartilage in symptomatic knee cartilage lesions.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Spheroids of human autologous matrix-associated chondrocytes (Spherox) is an advanced therapy medicinal product consisting of cartilage-repair constructs made from the patient's own chondrocytes embedded in a collagen matrix, used for the surgical repair of full-thickness cartilage defects in the knee. The three-dimensional spheroid architecture maintains chondrocyte phenotype and supports integration with surrounding native cartilage after arthroscopic implantation. It represents a cell therapy approach to restore hyaline-like cartilage in symptomatic knee cartilage lesions.

Yes, Spheroids Of Human Autologous Matrix-Associated Chondrocytes is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315113. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.